Cupertino, CA – Apple is specifically targeting the healthcare industry with the launch of their new Apple Watch along with their Healthkit framework to track and store your health data. While their iWatch has way more to be desired as a wearable health companion, these moves specifically aim their products at a segment that has already widely adopted the Apple platform.

Doximity, a social networking interface for physicians only, reports that 85% of their user base currently uses an iPhone. The report also noted that doctors are quick adopters of new devices, siting that one-third of doctors will upgrade to the new iPhone 6 by Thanksgiving.

The healthcare industry has notoriously lacked good design as well as complete disregard to user experience, leaving the market wide open to anyone with a little savvy in these areas to make great products. Apple is only one of the many companies, primarily big tech, who have seen this opening and are investing heavily on its future. As companies compete to gain market share, medical devices are certainly going to evolve to appeal to our visual senses.

1 out of every 5 dollars is spent on healthcare. So why wouldn’t Apple double down on devices that would improve our health? It almost seems like the perfect fit. And just like they influenced a revolution in the phone and music industry, Apple is positioning itself to drive product design and desire in the health and fitness space.

Apple Healthkit

About the Author:

As Managing Director of Innovation for Syneos Health Communications, Leigh is responsible for shaping the company’s perspective on the next era of healthcare marketing. Through thought leadership, strategic innovation workshops and new products and capabilities, Leigh focuses on identifying marketing approaches that will fuel that new era and generate significant growth for clients. Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for over 17 years. She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she had several leadership roles at one of our agencies, GSW. There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business. Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes. A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice, Leigh also was recognized as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.